CFDE Data Portal | Search SNHG31

	Label	Description
	SNHG31 Gene (Entity type)	ENSG00000229267 - small nucleolar RNA host gene 31
	GSE172219 adenosine 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE206931 WDR5 inhibition WIN 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE130401 trametinib YAP 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 paclitaxel 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

SNHG31

ENSG00000229267 - small nucleolar RNA host gene 31

GSE172219 adenosine 2 v 1 human dn

A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 3 v 6 human up

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 11 human up

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 0 v 3 human up

A Gene Set from LINCS

GSE130401 trametinib YAP 6 v 0 human dn

A Gene Set from LINCS

GSE113655 phenol 5 v 4 human dn

A Gene Set from LINCS

GSE172016 paclitaxel 2 v 1 human dn

A Gene Set from LINCS

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 3 human up

A Gene Set from LINCS

GSE76425 lenalidomide 0 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.